-
1
-
-
73449088379
-
Vaccines: the fourth century
-
[pii: CVI.00290-09]
-
Plotkin S.A. Vaccines: the fourth century. Clinical Vaccine Immunology 2009, 16:1709-1719. [pii: CVI.00290-09]. 10.1128/CVI.00290-09.
-
(2009)
Clinical Vaccine Immunology
, vol.16
, pp. 1709-1719
-
-
Plotkin, S.A.1
-
4
-
-
79952364267
-
Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine
-
[pii: S0264-410X(10)01736-6]
-
Barnighausen T., Bloom D.E., Canning D., Friedman A., Levine O.S., O'Brien J., et al. Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine. Vaccine 2011, 29:2371-2380. [pii: S0264-410X(10)01736-6]. 10.1016/j.vaccine.2010.11.090.
-
(2011)
Vaccine
, vol.29
, pp. 2371-2380
-
-
Barnighausen, T.1
Bloom, D.E.2
Canning, D.3
Friedman, A.4
Levine, O.S.5
O'Brien, J.6
-
5
-
-
84882268534
-
-
GAVI Alliance
-
The GAVI Alliance 2012, GAVI Alliance.
-
(2012)
The GAVI Alliance
-
-
-
8
-
-
78049509803
-
Global routine vaccination coverage, 2009
-
Centers for Disease Control Prevention, [pii: mm5942a3]
-
Global routine vaccination coverage, 2009. MMWR Morb Mortal Wkly Rep 59 2010, 1367-1371. Centers for Disease Control Prevention, [pii: mm5942a3].
-
(2010)
MMWR Morb Mortal Wkly Rep 59
, pp. 1367-1371
-
-
-
9
-
-
34250866280
-
The challenges of vaccine responses in early life: selected examples
-
[pii: S0021-9975(07)00052-7]
-
Siegrist C.A. The challenges of vaccine responses in early life: selected examples. Journal of Comparative Pathology 2007, 137(Suppl. 1):S4-S9. [pii: S0021-9975(07)00052-7]. 10.1016/j.jcpa.2007.04.004.
-
(2007)
Journal of Comparative Pathology
, vol.137
, Issue.SUPPL. 1
-
-
Siegrist, C.A.1
-
10
-
-
80053949404
-
Mucosal immunity to poliovirus
-
Ogra P.L., Okayasu H., Czerkinsky C., Sutter R.W. Mucosal immunity to poliovirus. Expert Review of Vaccines 2011, 10:1389-1392. 10.1586/erv.11.106.
-
(2011)
Expert Review of Vaccines
, vol.10
, pp. 1389-1392
-
-
Ogra, P.L.1
Okayasu, H.2
Czerkinsky, C.3
Sutter, R.W.4
-
11
-
-
75449098835
-
Effect of human rotavirus vaccine on severe diarrhea in African infants
-
[pii: 362/4/289]
-
Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. New England Journal of Medicine 2010, 362:289-298. [pii: 362/4/289]. 10.1056/NEJMoa0904797.
-
(2010)
New England Journal of Medicine
, vol.362
, pp. 289-298
-
-
Madhi, S.A.1
Cunliffe, N.A.2
Steele, D.3
Witte, D.4
Kirsten, M.5
Louw, C.6
-
12
-
-
0034014485
-
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
-
[pii: S0264410X00000062]
-
Richie E.E., Punjabi N.H., Sidharta Y.Y., Peetosutan K.K., Sukandar M.M., Wasserman S.S., et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 2000, 18:2399-2410. [pii: S0264410X00000062].
-
(2000)
Vaccine
, vol.18
, pp. 2399-2410
-
-
Richie, E.E.1
Punjabi, N.H.2
Sidharta, Y.Y.3
Peetosutan, K.K.4
Sukandar, M.M.5
Wasserman, S.S.6
-
13
-
-
84862674538
-
Vaccines against mucosal infections
-
[pii: S0952-7915(12)00063-5]
-
Holmgren J., Svennerholm A.M. Vaccines against mucosal infections. Current Opinion in Immunology 2012, 24:343-353. [pii: S0952-7915(12)00063-5]. 10.1016/j.coi.2012.03.014.
-
(2012)
Current Opinion in Immunology
, vol.24
, pp. 343-353
-
-
Holmgren, J.1
Svennerholm, A.M.2
-
14
-
-
0034679239
-
23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial
-
[pii: S0140673600023771]
-
French N., Nakiyingi J., Carpenter L.M., Lugada E., Watera C., Moi K., et al. 23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000, 355:2106-2111. [pii: S0140673600023771].
-
(2000)
Lancet
, vol.355
, pp. 2106-2111
-
-
French, N.1
Nakiyingi, J.2
Carpenter, L.M.3
Lugada, E.4
Watera, C.5
Moi, K.6
-
15
-
-
0038387430
-
Poor potential coverage for 7-valent pneumococcal conjugate vaccine
-
Gordon S.B., Kanyanda S., Walsh A.L., Goddard K., Chaponda M., Atkinson V., et al. Poor potential coverage for 7-valent pneumococcal conjugate vaccine. Emerging Infectious Diseases, Malawi 2003, 9:747-749. 10.3201/eid0906.030020.
-
(2003)
Emerging Infectious Diseases, Malawi
, vol.9
, pp. 747-749
-
-
Gordon, S.B.1
Kanyanda, S.2
Walsh, A.L.3
Goddard, K.4
Chaponda, M.5
Atkinson, V.6
-
16
-
-
79960897597
-
The future of immunisation policy, implementation, and financing
-
[pii: S0140-6736(11)60406-6]
-
Levine O.S., Bloom D.E., Cherian T., de Q.C., Sow S., Wecker J., et al. The future of immunisation policy, implementation, and financing. Lancet 2011, 378:439-448. [pii: S0140-6736(11)60406-6]. 10.1016/S0140-6736(11)60406-6.
-
(2011)
Lancet
, vol.378
, pp. 439-448
-
-
Levine, O.S.1
Bloom, D.E.2
Cherian, T.3
de, Q.C.4
Sow, S.5
Wecker, J.6
-
17
-
-
79955101797
-
Rotavirus vaccine RIX4414 (Rotarix): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries
-
[pii: 9]
-
Plosker G.L. Rotavirus vaccine RIX4414 (Rotarix): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries. Pharmacoeconomics 2011, 29:439-454. [pii: 9]. 10.2165/11207130-000000000-00000.
-
(2011)
Pharmacoeconomics
, vol.29
, pp. 439-454
-
-
Plosker, G.L.1
-
18
-
-
82255163007
-
Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines
-
[pii: S0140-6736(11)60687-9]
-
Hargreaves J.R., Greenwood B., Clift C., Goel A., Roemer-Mahler A., Smith R., et al. Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines. Lancet 2011, 378:1885-1893. [pii: S0140-6736(11)60687-9]. 10.1016/S0140-6736(11)60687-9.
-
(2011)
Lancet
, vol.378
, pp. 1885-1893
-
-
Hargreaves, J.R.1
Greenwood, B.2
Clift, C.3
Goel, A.4
Roemer-Mahler, A.5
Smith, R.6
-
19
-
-
78049523855
-
Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report
-
WHO
-
WHO Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report. Weekly Epidemiological Record, vol. 85 2010, 434-436.
-
(2010)
Weekly Epidemiological Record, vol. 85
, pp. 434-436
-
-
-
21
-
-
79959305905
-
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
-
Sow S.O., Okoko B.J., Diallo A., Viviani S., Borrow R., Carlone G., et al. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. New England Journal of Medicine 2011, 364:2293-2304. 10.1056/NEJMoa1003812.
-
(2011)
New England Journal of Medicine
, vol.364
, pp. 2293-2304
-
-
Sow, S.O.1
Okoko, B.J.2
Diallo, A.3
Viviani, S.4
Borrow, R.5
Carlone, G.6
-
23
-
-
84866614844
-
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
-
[pii: S1473-3099(12)70168-8]
-
Novak R.T., Kambou J.L., Diomande F.V., Tarbangdo T.F., Ouedraogo-Traore R., Sangare L., et al. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infectious Diseases 2012, [pii: S1473-3099(12)70168-8]. 10.1016/S1473-3099(12)70168-8.
-
(2012)
Lancet Infectious Diseases
-
-
Novak, R.T.1
Kambou, J.L.2
Diomande, F.V.3
Tarbangdo, T.F.4
Ouedraogo-Traore, R.5
Sangare, L.6
-
24
-
-
84872282456
-
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
-
[pii: cis892]
-
Kristiansen P.A., Diomande F., Ba A.K., Sanou I., Ouedraogo A.S., Ouedraogo R., et al. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clinical Infectious Disease 2012, [pii: cis892]. 10.1093/cid/cis892.
-
(2012)
Clinical Infectious Disease
-
-
Kristiansen, P.A.1
Diomande, F.2
Ba, A.K.3
Sanou, I.4
Ouedraogo, A.S.5
Ouedraogo, R.6
-
27
-
-
84882250704
-
-
Anonymous
-
Anonymous Aeras 2012.
-
(2012)
Aeras
-
-
-
28
-
-
81455154875
-
First results of Phase 3 trial of RTS, S/AS01 malaria vaccine in African children
-
Agnandji S.T., Lell B., Soulanoudjingar S.S., Fernandes J.F., Abossolo B.P., Conzelmann C., et al. First results of Phase 3 trial of RTS, S/AS01 malaria vaccine in African children. New England Journal of Medicine 2011, 365:1863-1875. 10.1056/NEJMoa1102287.
-
(2011)
New England Journal of Medicine
, vol.365
, pp. 1863-1875
-
-
Agnandji, S.T.1
Lell, B.2
Soulanoudjingar, S.S.3
Fernandes, J.F.4
Abossolo, B.P.5
Conzelmann, C.6
-
29
-
-
84871037616
-
A Phase 3 trial of RTS, S/AS01 malaria vaccine in African infants
-
RTS SCTP
-
A Phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. New England Journal of Medicine 2012, RTS SCTP. 10.1056/NEJMoa1208394.
-
(2012)
New England Journal of Medicine
-
-
-
30
-
-
84862641275
-
HIV vaccine design: the neutralizing antibody conundrum
-
[pii: S0952-7915(12)00066-0]
-
Stamatatos L. HIV vaccine design: the neutralizing antibody conundrum. Current Opinion in Immunology 2012, 24:316-323. [pii: S0952-7915(12)00066-0]. 10.1016/j.coi.2012.04.006.
-
(2012)
Current Opinion in Immunology
, vol.24
, pp. 316-323
-
-
Stamatatos, L.1
-
32
-
-
80052483841
-
Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries
-
[pii: 366/1579/2799]
-
Clemens J Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2011, 366:2799-2805. [pii: 366/1579/2799]. 10.1098/rstb.2011.0033.
-
(2011)
Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences
, vol.366
, pp. 2799-2805
-
-
Clemens, J.1
-
33
-
-
84882277715
-
-
University of Maryland School of Medicine
-
Global Enterics Multi-Center Study 2012, University of Maryland School of Medicine.
-
(2012)
Global Enterics Multi-Center Study
-
-
-
34
-
-
84865865034
-
Vaccines for typhoid fever and other salmonelloses
-
Martin L.B. Vaccines for typhoid fever and other salmonelloses. Current Opinion in Infectious Diseases 2012, 25:489-499. 10.1097/QCO.0b013e328356ffeb.
-
(2012)
Current Opinion in Infectious Diseases
, vol.25
, pp. 489-499
-
-
Martin, L.B.1
-
35
-
-
0035953692
-
The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children
-
Lin F.Y., Ho V.A., Khiem H.B., Trach D.D., Bay P.V., Thanh T.C., et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. The New England Journal of Medicine 2001, 344:1263-1269.
-
(2001)
The New England Journal of Medicine
, vol.344
, pp. 1263-1269
-
-
Lin, F.Y.1
Ho, V.A.2
Khiem, H.B.3
Trach, D.D.4
Bay, P.V.5
Thanh, T.C.6
-
36
-
-
84868672325
-
O:2-CRM(197) conjugates against Salmonella Paratyphi A
-
[pii: PONE-D-12-15743]
-
Micoli F., Rondini S., Gavini M., Lanzilao L., Medaglini D., Saul A., et al. O:2-CRM(197) conjugates against Salmonella Paratyphi A. PLoS ONE 2012, 7:e47039. [pii: PONE-D-12-15743]. 10.1371/journal.pone.0047039.
-
(2012)
PLoS ONE
, vol.7
-
-
Micoli, F.1
Rondini, S.2
Gavini, M.3
Lanzilao, L.4
Medaglini, D.5
Saul, A.6
-
37
-
-
84872029523
-
Glycoconjugate vaccine strategies for protection against invasive Salmonella infections
-
[pii: 19158]
-
Simon R., Levine M.M. Glycoconjugate vaccine strategies for protection against invasive Salmonella infections. Human Vaccines & Immunotherapeutics 2012, 8:494-498. [pii: 19158]. 10.4161/hv.19158.
-
(2012)
Human Vaccines & Immunotherapeutics
, vol.8
, pp. 494-498
-
-
Simon, R.1
Levine, M.M.2
-
38
-
-
42949093134
-
Shigellosis: the current status of vaccine development
-
[pii: 00001432-200806000-00016]
-
Kweon M.N. Shigellosis: the current status of vaccine development. Current Opinion in Infectious Diseases 2008, 21:313-318. [pii: 00001432-200806000-00016]. 10.1097/QCO.0b013e3282f88b92.
-
(2008)
Current Opinion in Infectious Diseases
, vol.21
, pp. 313-318
-
-
Kweon, M.N.1
-
39
-
-
82955178229
-
New-generation vaccines against cholera
-
[pii: nrgastro.2011.174]
-
Clemens J., Shin S., Sur D., Nair G.B., Holmgren J. New-generation vaccines against cholera. Nature Reviews Gastroenterology & Hepatology 2011, 8:701-710. [pii: nrgastro.2011.174]. 10.1038/nrgastro.2011.174.
-
(2011)
Nature Reviews Gastroenterology & Hepatology
, vol.8
, pp. 701-710
-
-
Clemens, J.1
Shin, S.2
Sur, D.3
Nair, G.B.4
Holmgren, J.5
-
40
-
-
33847043576
-
Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger
-
[pii: CID41097]
-
Boisier P., Nicolas P., Djibo S., Taha M.K., Jeanne I., Mainassara H.B., et al. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clinical Infectious Diseases 2007, 44:657-663. [pii: CID41097]. 10.1086/511646.
-
(2007)
Clinical Infectious Diseases
, vol.44
, pp. 657-663
-
-
Boisier, P.1
Nicolas, P.2
Djibo, S.3
Taha, M.K.4
Jeanne, I.5
Mainassara, H.B.6
-
41
-
-
34548422845
-
Control of neglected tropical diseases
-
[pii: 357/10/1018]
-
Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Sachs S.E., Sachs J.D., et al. Control of neglected tropical diseases. New England Journal of Medicine 2007, 357:1018-1027. [pii: 357/10/1018]. 10.1056/NEJMra064142.
-
(2007)
New England Journal of Medicine
, vol.357
, pp. 1018-1027
-
-
Hotez, P.J.1
Molyneux, D.H.2
Fenwick, A.3
Kumaresan, J.4
Sachs, S.E.5
Sachs, J.D.6
-
42
-
-
78650575238
-
Vaccines to combat the neglected tropical diseases
-
Bethony J.M., Cole R.N., Guo X., Kamhawi S., Lightowlers M.W., Loukas A., et al. Vaccines to combat the neglected tropical diseases. Immunological Reviews 2011, 239:237-270. 10.1111/j.1600-065X.2010.00976.x.
-
(2011)
Immunological Reviews
, vol.239
, pp. 237-270
-
-
Bethony, J.M.1
Cole, R.N.2
Guo, X.3
Kamhawi, S.4
Lightowlers, M.W.5
Loukas, A.6
-
46
-
-
77955697539
-
The Novartis Vaccines Institute for Global Health: a new initiative for developing vaccines for neglected diseases in developing countries
-
Saul A., Rappuoli R. The Novartis Vaccines Institute for Global Health: a new initiative for developing vaccines for neglected diseases in developing countries. Journal of Infection in Developing Countries 2008, 2:154-155.
-
(2008)
Journal of Infection in Developing Countries
, vol.2
, pp. 154-155
-
-
Saul, A.1
Rappuoli, R.2
-
47
-
-
80053582349
-
Safety, immunogenicity and dose ranging of a new Vi-CRM conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults
-
[pii: PONE-D-11-13873]
-
van D.P., Kafeja F., Anemona A., Basile V., Hilbert A.K., De C., et al. Safety, immunogenicity and dose ranging of a new Vi-CRM conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults. PLoS ONE 2011, 6:e25398. [pii: PONE-D-11-13873]. 10.1371/journal.pone.0025398.
-
(2011)
PLoS ONE
, vol.6
-
-
van, D.P.1
Kafeja, F.2
Anemona, A.3
Basile, V.4
Hilbert, A.K.5
De, C.6
-
49
-
-
0033968870
-
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa
-
[pii: S0140-6736(99)03366-8]
-
Woods C.W., Armstrong G., Sackey S.O., Tetteh C., Bugri S., Perkins B.A., et al. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa. Lancet 2000, 355:30-33. [pii: S0140-6736(99)03366-8]. 10.1016/S0140-6736(99)03366-8.
-
(2000)
Lancet
, vol.355
, pp. 30-33
-
-
Woods, C.W.1
Armstrong, G.2
Sackey, S.O.3
Tetteh, C.4
Bugri, S.5
Perkins, B.A.6
-
50
-
-
61349145533
-
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
-
[pii: nri2494]
-
Pollard A.J., Perrett K.P., Beverley P.C. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nature Reviews Immunology 2009, 9:213-220. [pii: nri2494]. 10.1038/nri2494.
-
(2009)
Nature Reviews Immunology
, vol.9
, pp. 213-220
-
-
Pollard, A.J.1
Perrett, K.P.2
Beverley, P.C.3
-
51
-
-
0033529658
-
Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood
-
MacLennan J., Obaro S., Deeks J., Williams D., Pais L., Carlone G., et al. Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. Vaccine 1999, 17:3086-3093.
-
(1999)
Vaccine
, vol.17
, pp. 3086-3093
-
-
MacLennan, J.1
Obaro, S.2
Deeks, J.3
Williams, D.4
Pais, L.5
Carlone, G.6
-
52
-
-
80052482936
-
Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers
-
[pii: CVI. 05020-11]
-
Findlow H., Sow S., Borrow R., Tapia M., Haidara F.C., Akinsola A.K., et al. Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers. Clinical Vaccine Immunology 2011, 18:1492-1496. [pii: CVI. 05020-11]. 10.1128/CVI.05020-11.
-
(2011)
Clinical Vaccine Immunology
, vol.18
, pp. 1492-1496
-
-
Findlow, H.1
Sow, S.2
Borrow, R.3
Tapia, M.4
Haidara, F.C.5
Akinsola, A.K.6
-
53
-
-
78650615093
-
Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi
-
[pii: S0264-410X(10)01631-2]
-
Micoli F., Rondini S., Pisoni I., Proietti D., Berti F., Costantino P., et al. Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi. Vaccine 2011, 29:712-720. [pii: S0264-410X(10)01631-2]. 10.1016/j.vaccine.2010.11.022.
-
(2011)
Vaccine
, vol.29
, pp. 712-720
-
-
Micoli, F.1
Rondini, S.2
Pisoni, I.3
Proietti, D.4
Berti, F.5
Costantino, P.6
-
54
-
-
77953009742
-
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus
-
[pii: 15ra5. 2/15/15ra5]
-
Khurana S., Chearwae W., Castellino F., Manischewitz J., King L.R., Honorkiewicz A., et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Science Translational Medicine 2010, 2. [pii: 15ra5. 2/15/15ra5]. 10.1126/scitranslmed.3000624.
-
(2010)
Science Translational Medicine
, vol.2
-
-
Khurana, S.1
Chearwae, W.2
Castellino, F.3
Manischewitz, J.4
King, L.R.5
Honorkiewicz, A.6
-
55
-
-
79957840765
-
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines
-
[pii: 85ra48. 3/85/85ra48]
-
Khurana S., Verma N., Yewdell J.W., Hilbert A.K., Castellino F., Lattanzi M., et al. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Science Translational Medicine 2011, 3. [pii: 85ra48. 3/85/85ra48]. 10.1126/scitranslmed.3002336.
-
(2011)
Science Translational Medicine
, vol.3
-
-
Khurana, S.1
Verma, N.2
Yewdell, J.W.3
Hilbert, A.K.4
Castellino, F.5
Lattanzi, M.6
-
56
-
-
84862659753
-
Adjuvants for human vaccines
-
[pii: S0952-7915(12)00054-4]
-
Alving C.R., Peachman K.K., Rao M., Reed S.G. Adjuvants for human vaccines. Current Opinion in Immunology 2012, 24:310-315. [pii: S0952-7915(12)00054-4]. 10.1016/j.coi.2012.03.008.
-
(2012)
Current Opinion in Immunology
, vol.24
, pp. 310-315
-
-
Alving, C.R.1
Peachman, K.K.2
Rao, M.3
Reed, S.G.4
-
57
-
-
0034629284
-
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
-
[pii: 8343]
-
Pizza M., Scarlato V., Masignani V., Giuliani M.M., Arico B., Comanducci M., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-1820. [pii: 8343].
-
(2000)
Science
, vol.287
, pp. 1816-1820
-
-
Pizza, M.1
Scarlato, V.2
Masignani, V.3
Giuliani, M.M.4
Arico, B.5
Comanducci, M.6
-
58
-
-
77958454595
-
Reverse vaccinology: developing vaccines in the era of genomics
-
[pii: S1074-7613(10)00360-2]
-
Sette A., Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010, 33:530-541. [pii: S1074-7613(10)00360-2]. 10.1016/j.immuni.2010.09.017.
-
(2010)
Immunity
, vol.33
, pp. 530-541
-
-
Sette, A.1
Rappuoli, R.2
-
59
-
-
0037451178
-
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
-
[pii: jem.20021911]
-
Masignani V., Comanducci M., Giuliani M.M., Bambini S., Adu-Bobie J., Arico B., et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. Journal of Experimental Medicine 2003, 197:789-799. [pii: jem.20021911]. 10.1084/jem.20021911.
-
(2003)
Journal of Experimental Medicine
, vol.197
, pp. 789-799
-
-
Masignani, V.1
Comanducci, M.2
Giuliani, M.M.3
Bambini, S.4
Adu-Bobie, J.5
Arico, B.6
-
60
-
-
12144290906
-
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
-
Fletcher L.D., Bernfield L., Barniak V., Farley J.E., Howell A., Knauf M., et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infection and Immunity 2004, 72:2088-2100.
-
(2004)
Infection and Immunity
, vol.72
, pp. 2088-2100
-
-
Fletcher, L.D.1
Bernfield, L.2
Barniak, V.3
Farley, J.E.4
Howell, A.5
Knauf, M.6
-
61
-
-
65649149729
-
Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa
-
Beernink P.T., Caugant D.A., Welsch J.A., Koeberling O., Granoff D.M. Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. Journal of Infectious Diseases 2009, 199:1360-1368. 10.1086/597806.
-
(2009)
Journal of Infectious Diseases
, vol.199
, pp. 1360-1368
-
-
Beernink, P.T.1
Caugant, D.A.2
Welsch, J.A.3
Koeberling, O.4
Granoff, D.M.5
-
62
-
-
80053451952
-
Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development
-
[pii: PNTD-D-11-00158]
-
Pajon R., Fergus A.M., Koeberling O., Caugant D.A., Granoff D.M. Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development. PLOS Neglected Tropical Diseases 2011, 5:e1302. [pii: PNTD-D-11-00158]. 10.1371/journal.pntd.0001302.
-
(2011)
PLOS Neglected Tropical Diseases
, vol.5
-
-
Pajon, R.1
Fergus, A.M.2
Koeberling, O.3
Caugant, D.A.4
Granoff, D.M.5
-
63
-
-
84862330001
-
Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case
-
[pii: M111.M111.015693]
-
Bensi G., Mora M., Tuscano G., Biagini M., Chiarot E., Bombaci M., et al. Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case. Molecular and Cellular Proteomics 2012, 11. [pii: M111.M111.015693]. 10.1074/mcp.M111.015693.
-
(2012)
Molecular and Cellular Proteomics
, vol.11
-
-
Bensi, G.1
Mora, M.2
Tuscano, G.3
Biagini, M.4
Chiarot, E.5
Bombaci, M.6
-
64
-
-
33751120945
-
Group B Streptococcus: global incidence and vaccine development
-
[pii: nrmicro1552]
-
Johri A.K., Paoletti L.C., Glaser P., Dua M., Sharma P.K., Grandi G., et al. Group B Streptococcus: global incidence and vaccine development. Nature Reviews Microbiology 2006, 4:932-942. [pii: nrmicro1552]. 10.1038/nrmicro1552.
-
(2006)
Nature Reviews Microbiology
, vol.4
, pp. 932-942
-
-
Johri, A.K.1
Paoletti, L.C.2
Glaser, P.3
Dua, M.4
Sharma, P.K.5
Grandi, G.6
-
65
-
-
77952692819
-
Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli
-
[pii: 0915077107]
-
Moriel D.G., Bertoldi I., Spagnuolo A., Marchi S., Rosini R., Nesta B., et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:9072-9077. [pii: 0915077107]. 10.1073/pnas.0915077107.
-
(2010)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, pp. 9072-9077
-
-
Moriel, D.G.1
Bertoldi, I.2
Spagnuolo, A.3
Marchi, S.4
Rosini, R.5
Nesta, B.6
-
66
-
-
84862018230
-
High yield production process for Shigella outer membrane particles
-
[pii: PONE-D-11-12924]
-
Berlanda S.F., Colucci A.M., Maggiore L., Sanzone S., Rossi O., Ferlenghi I., et al. High yield production process for Shigella outer membrane particles. PLoS ONE 2012, 7:e35616. [pii: PONE-D-11-12924]. 10.1371/journal.pone.0035616.
-
(2012)
PLoS ONE
, vol.7
-
-
Berlanda, S.F.1
Colucci, A.M.2
Maggiore, L.3
Sanzone, S.4
Rossi, O.5
Ferlenghi, I.6
-
67
-
-
77957959533
-
Biological functions and biogenesis of secreted bacterial outer membrane vesicles
-
Kulp A., Kuehn M.J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annual Review of Microbiology 2010, 64:163-184. 10.1146/annurev.micro.091208.073413.
-
(2010)
Annual Review of Microbiology
, vol.64
, pp. 163-184
-
-
Kulp, A.1
Kuehn, M.J.2
-
68
-
-
33645473483
-
Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles
-
Ferrari G., Garaguso I., Adu-Bobie J., Doro F., Taddei A.R., Biolchi A., et al. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 2006, 6:1856-1866. 10.1002/pmic.200500164.
-
(2006)
Proteomics
, vol.6
, pp. 1856-1866
-
-
Ferrari, G.1
Garaguso, I.2
Adu-Bobie, J.3
Doro, F.4
Taddei, A.R.5
Biolchi, A.6
-
69
-
-
70349406755
-
Phase II meningococcal B vesicle vaccine trial in New Zealand infants
-
[pii: adc.2007.132571]
-
Jackson C., Lennon D.R., Sotutu V.T., Yan J., Stewart J.M., Reid S., et al. Phase II meningococcal B vesicle vaccine trial in New Zealand infants. Archives of Disease in Childhood 2009, 94:745-751. [pii: adc.2007.132571]. 10.1136/adc.2007.132571.
-
(2009)
Archives of Disease in Childhood
, vol.94
, pp. 745-751
-
-
Jackson, C.1
Lennon, D.R.2
Sotutu, V.T.3
Yan, J.4
Stewart, J.M.5
Reid, S.6
-
70
-
-
79955738990
-
A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines
-
[pii: CV. I.00542-10]
-
Koeberling O., Delany I., Granoff D.M. A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines. Clinical Vaccine Immunology 2011, 18:736-742. [pii: CV. I.00542-10]. 10.1128/CVI. 00542-10.
-
(2011)
Clinical Vaccine Immunology
, vol.18
, pp. 736-742
-
-
Koeberling, O.1
Delany, I.2
Granoff, D.M.3
-
71
-
-
79960621930
-
Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys
-
[pii: S0264-410X(11)00650-5]
-
Koeberling O., Seubert A., Santos G., Colaprico A., Ugozzoli M., Donnelly J., et al. Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys. Vaccine 2011, 29:4728-4734. [pii: S0264-410X(11)00650-5]. 10.1016/j.vaccine.2011.04.095.
-
(2011)
Vaccine
, vol.29
, pp. 4728-4734
-
-
Koeberling, O.1
Seubert, A.2
Santos, G.3
Colaprico, A.4
Ugozzoli, M.5
Donnelly, J.6
-
72
-
-
84855354748
-
Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide
-
[pii: S0264-410X(11)01880-9]
-
Zollinger W.D., Babcock J.G., Moran E.E., Brandt B.L., Matyas G.R., Wassef N.M., et al. Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide. Vaccine 2012, 30:712-721. [pii: S0264-410X(11)01880-9]. 10.1016/j.vaccine.2011.11.084.
-
(2012)
Vaccine
, vol.30
, pp. 712-721
-
-
Zollinger, W.D.1
Babcock, J.G.2
Moran, E.E.3
Brandt, B.L.4
Matyas, G.R.5
Wassef, N.M.6
-
73
-
-
84855453738
-
Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi
-
[pii: S0264-410X(11)01904-9]
-
Micoli F., Rondini S., Pisoni I., Giannelli C., Di C., Costantino V., et al. Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi. Vaccine 2012, 30:853-861. [pii: S0264-410X(11)01904-9]. 10.1016/j.vaccine.2011.11.108.
-
(2012)
Vaccine
, vol.30
, pp. 853-861
-
-
Micoli, F.1
Rondini, S.2
Pisoni, I.3
Giannelli, C.4
Di, C.5
Costantino, V.6
-
77
-
-
78650604587
-
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
-
[pii: 1013758107]
-
Donnelly J., Medini D., Boccadifuoco G., Biolchi A., Ward J., Frasch C., et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:19490-19495. [pii: 1013758107]. 10.1073/pnas.1013758107.
-
(2010)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, pp. 19490-19495
-
-
Donnelly, J.1
Medini, D.2
Boccadifuoco, G.3
Biolchi, A.4
Ward, J.5
Frasch, C.6
-
78
-
-
84870658532
-
Desirable attributes of vaccines for deployment in low-resource settings
-
Chen D., Zehrung D. Desirable attributes of vaccines for deployment in low-resource settings. Journal of Pharmaceutical Sciences 2012, 10.1002/jps.23352.
-
(2012)
Journal of Pharmaceutical Sciences
-
-
Chen, D.1
Zehrung, D.2
-
80
-
-
58949103422
-
Burden of neonatal infections in developing countries: a review of evidence from community-based studies
-
[pii: 00006454-200901001-00002]
-
Thaver D., Zaidi A.K. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatric Infectious Disease Journal 2009, 28:S3-S9. [pii: 00006454-200901001-00002]. 10.1097/INF.0b013e3181958755.
-
(2009)
Pediatric Infectious Disease Journal
, vol.28
-
-
Thaver, D.1
Zaidi, A.K.2
-
82
-
-
84865683817
-
Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe
-
[pii: ng.2369]
-
Holt K.E., Baker S., Weill F.X., Holmes E.C., Kitchen A., Yu J., et al. Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nature Genetics 2012, 44:1056-1059. [pii: ng.2369]. 10.1038/ng.2369.
-
(2012)
Nature Genetics
, vol.44
, pp. 1056-1059
-
-
Holt, K.E.1
Baker, S.2
Weill, F.X.3
Holmes, E.C.4
Kitchen, A.5
Yu, J.6
-
83
-
-
48349124258
-
High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi
-
[pii: ng.195]
-
Holt K.E., Parkhill J., Mazzoni C.J., Roumagnac P., Weill F.X., Goodhead I., et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nature Genetics 2008, 40:987-993. [pii: ng.195]. 10.1038/ng.195.
-
(2008)
Nature Genetics
, vol.40
, pp. 987-993
-
-
Holt, K.E.1
Parkhill, J.2
Mazzoni, C.J.3
Roumagnac, P.4
Weill, F.X.5
Goodhead, I.6
-
84
-
-
84868201561
-
Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa
-
[pii: ng.2423]
-
Okoro C.K., Kingsley R.A., Connor T.R., Harris S.R., Parry C.M., Al-Mashhadani M.N., et al. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nature Genetics 2012, 44:1215-1221. [pii: ng.2423]. 10.1038/ng.2423.
-
(2012)
Nature Genetics
, vol.44
, pp. 1215-1221
-
-
Okoro, C.K.1
Kingsley, R.A.2
Connor, T.R.3
Harris, S.R.4
Parry, C.M.5
Al-Mashhadani, M.N.6
-
85
-
-
3142658485
-
Genetic regulation of immune responses to vaccines in early life
-
[pii: 6364051]
-
Newport M.J., Goetghebuer T., Weiss H.A., Whittle H., Siegrist C.A., Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes Immun 2004, 5:122-129. [pii: 6364051]. 10.1038/sj.gene.6364051.
-
(2004)
Genes Immun
, vol.5
, pp. 122-129
-
-
Newport, M.J.1
Goetghebuer, T.2
Weiss, H.A.3
Whittle, H.4
Siegrist, C.A.5
Marchant, A.6
-
86
-
-
84857190262
-
Human genetic susceptibility to infectious disease
-
[pii: nrg3114]
-
Chapman S.J., Hill A.V. Human genetic susceptibility to infectious disease. Nature Reviews Genetics 2012, 13:175-188. [pii: nrg3114]. 10.1038/nrg3114.
-
(2012)
Nature Reviews Genetics
, vol.13
, pp. 175-188
-
-
Chapman, S.J.1
Hill, A.V.2
-
87
-
-
84856654988
-
Evolution, revolution and heresy in the genetics of infectious disease susceptibility
-
[pii: rstb.2011.0275]
-
Hill A.V. Evolution, revolution and heresy in the genetics of infectious disease susceptibility. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2012, 367:840-849. [pii: rstb.2011.0275]. 10.1098/rstb.2011.0275.
-
(2012)
Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences
, vol.367
, pp. 840-849
-
-
Hill, A.V.1
-
88
-
-
77952652892
-
Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis
-
[pii: S1473-3099(10)70072-4]
-
Reddy E.A., Shaw A.V., Crump J.A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infectious Diseases 2010, 10:417-432. [pii: S1473-3099(10)70072-4]. 10.1016/S1473-3099(10)70072-4.
-
(2010)
Lancet Infectious Diseases
, vol.10
, pp. 417-432
-
-
Reddy, E.A.1
Shaw, A.V.2
Crump, J.A.3
-
89
-
-
84862886432
-
Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa
-
[pii: S0140-6736(11)61752-2]
-
Feasey N.A., Dougan G., Kingsley R.A., Heyderman R.S., Gordon M.A. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012, 379:2489-2499. [pii: S0140-6736(11)61752-2]. 10.1016/S0140-6736(11)61752-2.
-
(2012)
Lancet
, vol.379
, pp. 2489-2499
-
-
Feasey, N.A.1
Dougan, G.2
Kingsley, R.A.3
Heyderman, R.S.4
Gordon, M.A.5
-
90
-
-
0023255605
-
Plasmodium falciparum malaria and Salmonella infections in Gambian children
-
Mabey D.C., Brown A., Greenwood B.M. Plasmodium falciparum malaria and Salmonella infections in Gambian children. The Journal of infectious diseases 1987, 155:1319-1321.
-
(1987)
The Journal of infectious diseases
, vol.155
, pp. 1319-1321
-
-
Mabey, D.C.1
Brown, A.2
Greenwood, B.M.3
-
91
-
-
80051668428
-
Coalition against Typhoid (CaT): a new, global initiative to advance typhoid vaccination
-
[pii: S0264-410X(11)00870-X]
-
Nelson C.B., de Q.C. Coalition against Typhoid (CaT): a new, global initiative to advance typhoid vaccination. Vaccine 2011, 29:6443. [pii: S0264-410X(11)00870-X]. 10.1016/j.vaccine.2011.06.006.
-
(2011)
Vaccine
, vol.29
, pp. 6443
-
-
Nelson, C.B.1
de, Q.C.2
-
92
-
-
73149112813
-
Lymphocyte subsets in healthy Malawians: implications for immunologic assessment of HIV infection in Africa
-
[pii: S0091-6749(09)01536-X]
-
Mandala W.L., MacLennan J.M., Gondwe E.N., Ward S.A., Molyneux M.E., MacLennan C.A. Lymphocyte subsets in healthy Malawians: implications for immunologic assessment of HIV infection in Africa. Journal of Allergy and Clinical Immunology 2010, 125:203-208. [pii: S0091-6749(09)01536-X]. 10.1016/j.jaci.2009.10.010.
-
(2010)
Journal of Allergy and Clinical Immunology
, vol.125
, pp. 203-208
-
-
Mandala, W.L.1
MacLennan, J.M.2
Gondwe, E.N.3
Ward, S.A.4
Molyneux, M.E.5
MacLennan, C.A.6
|